Impact of brain tumour treatment on quality of life

[1]  M. Taphoorn,et al.  Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Taphoorn,et al.  Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas , 2001, Neurology.

[3]  M. Bernstein,et al.  Quality of life in patients with glioblastoma multiforme participating in a randomized study of brachytherapy as a boost treatment. , 2000, Journal of neurosurgery.

[4]  D. Osoba,et al.  Effect of disease burden on health-related quality of life in patients with malignant gliomas. , 2000, Neuro-oncology.

[5]  N. Aaronson,et al.  How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Osoba,et al.  Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide. , 2000, European journal of cancer.

[7]  M. Gilbert,et al.  Issues in assessing and interpreting quality of life in patients with malignant glioma. , 2000, Seminars in oncology.

[8]  D. Osoba,et al.  Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  I. Whittle,et al.  Mood disorders in patients after treatment for primary intracranial tumours. , 1999, British journal of neurosurgery.

[10]  A. Giovagnoli.  Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumour , 1999, Journal of neurology, neurosurgery, and psychiatry.

[11]  Desmond Curran,et al.  Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844) , 1998 .

[12]  D. Osoba,et al.  Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma , 1997, Journal of Neuro-Oncology.

[13]  D. Osoba,et al.  The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires , 1996, Quality of Life Research.

[14]  P Maguire,et al.  Confiding in crisis: gender differences in pattern of confiding among cancer patients. , 1995, Social science & medicine.

[15]  S. Fosså,et al.  Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  D. Cella,et al.  The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT‐G) in patients with primary brain tumors , 1995, Cancer.

[17]  T M Gill,et al.  A critical appraisal of the quality of quality-of-life measurements. , 1994, JAMA.

[18]  A. Karim,et al.  Cognitive functions and quality of life in patients with low‐grade gliomas: The impact of radiotherapy , 1994, Annals of neurology.

[19]  D. Nelson,et al.  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.

[20]  N. Mackworth,et al.  Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores , 1992, Journal of Neuro-Oncology.

[21]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[22]  A. Karim,et al.  Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[23]  D Riddoch,et al.  Neoplasms of the central nervous system. , 1977, The Practitioner.

[24]  P. Moots.  Pitfalls in the management of patients with malignant gliomas. , 1998, Seminars in neurology.

[25]  G. Lyons.  The 'PRESTON Profile'--the first disease-specific tool for assessing quality of life in patients with malignant glioma. , 1996, Disability and rehabilitation.

[26]  C. Meyers,et al.  Psychosocial functioning and quality of life in patients with primary brain tumors. , 1996, Journal of neurosurgery.